PHARMACEUTICAL PREPARATIONS, NAMELY, ENZYME-BASED DRUGS FOR THE TREATMENT OF REPERFUSION INJURY FOLLOWING AN ISCHEMIC EVENT (MYOCARDIAL INFARCT OR STROKE), RESTENOSIS FOLLOWING ANGIOPLASTY, AND CHRONIC WOUNDS